We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Chronic Lymphocytic Leukemia (CLL) can affect the skin, causing lesions and increasing the risk of skin cancer. Learn about symptoms, diagnosis, treatment, and prevention.

Chronic Lymphocytic Leukemia (CLL) is a type of cancer that affects the blood and bone marrow, specifically the lymphocytes, which are a type of white blood cell crucial for the immune system. While often associated with internal symptoms, CLL can also manifest on the skin, leading to various lesions and conditions. It is estimated that up to 25% of individuals with CLL may experience skin-related issues. Furthermore, CLL can increase the risk of developing secondary skin cancers, making regular skin monitoring essential.
Skin lesions in people with CLL, often referred to as 'leukemia cutis,' can present in several ways. These manifestations can differ significantly from person to person, but common symptoms include:
Additionally, CLL can lead to easier bruising or bleeding, which might also be noticeable on the skin.
CLL is a slow-growing leukemia. In this condition, blood stem cells that should develop into healthy red blood cells, white blood cells, or platelets malfunction and transform into atypical lymphocytes. These abnormal lymphocytes, also called leukemia cells, can accumulate in the blood and bone marrow, eventually spreading to other parts of the body, including the skin. The overproduction of lymphocytes can disrupt the normal function of blood cells and contribute to the development of skin lesions and an increased susceptibility to infections.
The appearance of leukemia cutis can vary widely. It might manifest as:
It is important to note that these lesions may not always be directly indicative of active leukemia in the skin but can be a sign of the body's reaction to the disease or its treatment.
One of the significant concerns for individuals with CLL is an elevated risk of developing secondary skin cancers. Research suggests that people with CLL may be up to eight times more likely to develop skin cancers compared to the general population. These secondary cancers can include:
Given this increased risk, regular and thorough skin checks are crucial for early detection and prompt treatment.
It is vital to be vigilant about any changes in your skin. You should contact a doctor or a dermatologist immediately if you notice any of the following:
Early detection of skin cancer significantly improves treatment outcomes and prognosis.
Diagnosing skin lesions associated with CLL typically involves a combination of clinical examination and diagnostic tests. A dermatologist may perform:
The primary goal of treating skin lesions related to CLL is to manage the underlying leukemia. Treatment strategies for CLL itself may include:
In addition to treating the underlying cancer, managing specific skin symptoms might be necessary. For instance, skin infections may require antibiotics. Symptomatic treatment for itching or inflammation might also be recommended.
While CLL itself cannot always be prevented, proactive measures can help manage skin health and reduce risks:
CLL is generally considered a slow-progressing cancer, and many individuals live for years after diagnosis. The survival rate is relatively good, with approximately 88% of people living for at least 5 years post-diagnosis. However, this can vary significantly depending on the stage of the cancer at diagnosis and the individual's overall health. Early detection and effective management of both CLL and its associated skin conditions are key to a better prognosis.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026